NMPA Approval

Leuprorelin Acetate Microspheres Sustained Release For Injection

Approval Number

国药准字H20093809

Company北京博恩特药业有限公司

Registration Date

April 3, 2024

Drug Information

Generic Name

注射用醋酸亮丙瑞林缓释微球

Brand Name

博恩诺康

Dosage Form

注射剂

Strength

每瓶含醋酸亮丙瑞林3.75mg

Drug Type

化学药品

Registration Date

April 3, 2024

Company Information

Applicant Company

Company Name北京博恩特药业有限公司

Company Address

北京市密云区经济开发区永全街1号

Manufacturing Company

Company Name北京博恩特药业有限公司

Company Address

北京市密云区经济开发区永全街1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用醋酸亮丙瑞林缓释微球 - NMPA 批准文号 | MedPath